Crescita Therapeutics Inc T.CTX

Alternate Symbol(s): CRRTF

Healthcare Drug Manufacturers - Specialty & Generic

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company’s prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products ...

TSX:CTX - Post by User

Crescita Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

(1176)
•••

Post by lscfaon Mar 18, 2025 1:06pm

137 Views

Post# 36498483

Q4 results

Qtr ending	Skincare	Licensing	Manufacturing	Total rev	ebitda
Dec 24	3,230	303	3,369	6,902	151
Sep 24	2,703	457	434	3,594	(681)
Jun 24	2,972	491	625	4,088	(686)
Mar 24	2,535	0	2,461	4,996	(325)
Dec 23	2,851	1,547	327	4,725	245
Sep 23	2,412	163	458	3,033	(988)
Jun 23	2,685	299	2,178	5,162	214
Mar 23	2,492	21	2,089	4,602	161
Dec 22	2,422	1,481	2,127	6,030	997
Sep 22	1,672	92	4,268	6,032	512
Jun 22	2,392	227	3,893	6,512	646
Mar 22	1,536	0	3,415	4,951	66